Blood bank reagents
Ended Awarded Last action
- Contract number
- HT941024F0164
- Awardee
-
Werfen USA LLC UEI JA87HT8KP2M2
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $161,335
Award facts
- Contract value 67% obligated
-
- $161,334.56 Current, with exercised options
- $242,001.84 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Norcross, GA, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $80,667 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $80,667 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a delivery order to Werfen USA LLC on September 18, 2024, for blood bank reagents valued at $242,001.84, with performance completion expected by September 30, 2027. This firm fixed-price delivery order is issued under the In Vitro Diagnostics, Reagents, and Test GSA Schedule (FSS-65-VII) and will be performed in Norcross, Georgia. The award includes no small business set-aside designation and represents continued procurement of specialized diagnostic consumables that support blood banking operations across Department of Defense medical treatment facilities.
Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and laboratory reagents, brings extensive federal contracting experience to this engagement. The company operates as a full-sized contractor and maintains a substantial portfolio of indefinite delivery vehicle contracts with the Veterans Health Administration and Defense Health Agency, totaling millions of dollars for blood bank analyzers, coagulation testing equipment, and associated consumables. This delivery order leverages the established GSA Schedule vehicle, enabling the Defense Health Agency to efficiently procure blood bank reagents on an as-needed basis while maintaining budgetary certainty through the established ceiling value.
Quick answers
Who was awarded contract HT941024F0164?
HT941024F0164 was awarded to Werfen USA LLC by Defense Health Agency (Department of Defense) on September 18, 2024.
How much is contract HT941024F0164 worth?
The government has obligated $161,335 on HT941024F0164. Its potential value, with all options, is $242,002.
Is contract HT941024F0164 an order under another contract?
Yes. HT941024F0164 is a delivery order under V797D70110, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract HT941024F0164 competed?
The extent of competition for HT941024F0164 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award